← All trials
NCT05784012
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 8, 2023
- Primary completion
- Sep 30, 2027
- Completion date
- Mar 31, 2029
- First posted
- Mar 24, 2023
- Last posted
- Dec 15, 2023
- Enrollment
- 34
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Grupo Español de Tratamiento de Tumores de Cabeza y CuelloLead sponsor
- GlaxoSmithKlineCollaborator
- MFAR Clinical ResearchCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.